CD63 and breast carcinoma: Additionally, it has been shown that CD9 and CD63 are present in distinct structures in human platelets (Brisson et al., 1997) as well as in mouse breast cancer cells (Bobrie et al., 2012) and HeLa cells (Mathieu et al., 2021).